Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.37	34.1	32.4	12.59	36.83	45
Short-Term Investments	83.88	73.53	50.57	107.92	-	-
Cash & Short-Term Investments	103.26	107.62	82.97	120.51	36.83	45
Cash Growth	41.80%	29.71%	-31.15%	227.21%	-18.16%	-21.48%
Other Receivables	0.46	0.53	0.49	-	-	-
Receivables	0.46	0.53	0.49	-	-	-
Prepaid Expenses	1.53	0.94	3.62	0.8	0.89	1
Other Current Assets	0.37	0.34	0.47	1.31	0.24	0.27
Total Current Assets	105.62	109.43	87.55	122.62	37.96	46.27
Property, Plant & Equipment	1.14	1.23	1.56	0.19	0.18	0.33
Other Long-Term Assets	0.24	0.24	0.3	0.21	0.33	0.53
Total Assets	107	110.9	89.4	123.02	38.48	47.13
Accounts Payable	1.42	3.41	1.81	2.86	2.85	2.02
Accrued Expenses	5.17	6.81	3.71	3.52	3.81	3.43
Current Portion of Long-Term Debt	-	-	-	7	5.95	-
Current Portion of Leases	0.28	0.29	0.31	0.03	0.12	0.11
Total Current Liabilities	6.87	10.51	5.82	13.4	12.72	5.56
Long-Term Debt	-	-	-	2.15	8.65	13.95
Long-Term Leases	0.68	0.75	1.03	0	0.02	0.14
Other Long-Term Liabilities	-	-	-	0	-	0.2
Total Liabilities	7.55	11.26	6.86	15.56	21.4	19.85
Common Stock	0.1	0.09	0.07	0.06	0.03	0.02
Additional Paid-In Capital	396.67	386.53	321.64	317.59	197.96	174.24
Retained Earnings	-297.39	-287.05	-239.13	-210.07	-180.92	-146.98
Comprehensive Income & Other	0.07	0.06	-0.03	-0.12	-	-
Total Common Equity	99.46	99.64	82.55	107.46	17.08	27.28
Shareholders' Equity	99.46	99.64	82.55	107.46	17.08	27.28
Total Liabilities & Equity	107	110.9	89.4	123.02	38.48	47.13
Total Debt	0.96	1.03	1.34	9.18	14.74	14.21
Net Cash (Debt)	102.3	106.59	81.63	111.33	22.09	30.79
Net Cash Growth	42.98%	30.57%	-26.68%	404.06%	-28.27%	-45.94%
Net Cash Per Share	0.96	1.05	0.82	1.72	0.97	1.70
Filing Date Shares Outstanding	101.74	96.68	68.96	60.05	30.81	19.91
Total Common Shares Outstanding	99.89	93.6	68.28	59.94	28.51	18.55
Working Capital	98.76	98.92	81.72	109.22	25.23	40.71
Book Value Per Share	1.00	1.06	1.21	1.79	0.60	1.47
Tangible Book Value	99.46	99.64	82.55	107.46	17.08	27.28
Tangible Book Value Per Share	1.00	1.06	1.21	1.79	0.60	1.47
Machinery	-	0.35	0.3	0.21	0.11	0.11
Construction In Progress	-	0.01	0.02	0.05	-	-
Leasehold Improvements	-	0.03	0.03	0.13	0.13	0.13

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q